This digital health app predicts inflammatory bowel disease flare-ups by analyzing daily heart rate variability and stress levels. It provides personalized recommendations to help patients manage their condition and mitigate flare-up severity.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, often struggle with unpredictable flare-ups and varying symptom activity, making it difficult to manage their condition and plan their daily lives. Existing management approaches may not provide sufficient personalized insights into disease progression and potential triggers.
Solution
Coreway offers a mobile application designed to predict disease flare-ups and symptom activity in individuals with IBD, providing them with greater control over their condition. By analyzing daily user inputs and heart rate variability, the app aims to forecast potential flare-ups in the coming days. This enables users to proactively adjust their lifestyle, diet, and rest patterns to mitigate the severity of predicted flare-ups. The app also provides a daily overview dashboard to help users track their data and gain a better understanding of their condition.
Target Audience
The primary target audience consists of individuals diagnosed with chronic inflammatory bowel diseases (IBD) like Crohn's disease or ulcerative colitis, who are seeking a tool to better manage their condition and predict flare-ups.
Features
- Daily questionnaire for users to input relevant health data and lifestyle factors.
- Analysis of heart rate variability (HRV) to identify physiological patterns associated with flare-ups.
- Predictive algorithms to forecast disease flare-ups and symptom activity.
- Personalized recommendations for managing the condition and mitigating flare-up severity.
- Daily dashboard providing an overview of user data and predictions.
- Informative articles to help users positively influence their lifestyle.
- Option to track entries up to 3 days retroactively.